GNPX GENPREX INC Contract Awards 8-K Filing 2023 - New Contract Genprex, Inc. and the University of Pittsburgh have entered into an exclusive license agreement, where Genprex will be granted a worldwide license for certain patents and technologies for gene therapy for Type 1 and Type 2 diabetes. The agreement requires Genprex to pay an initial license fee, annual maintenance fees, royalties, and milestone payments totaling approximately $4,225,000.Get access to all SEC 8-K filings of the GENPREX INC